Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
clinical trials
deals
fda
investing
2
×
life sciences
national blog main
san francisco blog main
akouos
astellas pharmaceuticals
avapritinib
blueprint medicines
boston top stories
california institute for biomedical research
cstone pharmaceuticals
decibel therapeutics
eli lilly
european medicines agency
fisogatinib
flatiron health
frequency therapeutics
genentech
harvard university
hearing loss
hepatocellular carcinoma
jeff albers
jeffrey karp
medullary thyroid cancer
multiple sclerosis
national top stories
non-small cell lung cancer
perceptive life sciences
pralsetinib
regenerative medicine
robert langer
roche
san francisco top stories
selpercatinib
What
drug
2
×
fda
medicines
affects
americans
approval
approved
blueprint
cancer
candidate
currently
date
developing
frequency
hearing
ipo
loss
marketing
meds
millions
muscle
pact
plans
regenerative
regulatory
ret
review
roche
team
therapeutics
treat
wins
Language
unset
Current search:
drug
×
boston
×
investing
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds